FeesSafety
Pluang+

Markel Insurance appoints new heads for Transport & Logistics and Marine Liability to boost specialized underwriting.

Market News
15 Sep 2026
PRNewsWire
View Source
Bullish
Markel Insurance appoints new heads for Transport & Logistics and Marine Liability to boost specialized underwriting.

Markel Insurance has appointed Dean Johnson as Head of Transport & Logistics and Rhys O'Neill as Head of Marine Liability to strengthen its new Marine Transportation business. These roles aim to enhance underwriting expertise and portfolio growth amid complex risks like geopolitical tensions and supply chain disruptions. Both leaders will focus on delivering tailored insurance solutions and improving broker engagement to support sustainable expansion and client needs. Their appointments reflect Markel's commitment to addressing evolving risks in marine and energy sectors with specialized services.

Markel International's leadership appointments in Marine Transportation provide context for market activity in the Financials sector on Pluang. For readers following Financials stocks, here is Pluang's market snapshot as of Sep 15, 2026 13:41 WIB: out of 74 priced stocks, 31 rose and 38 fell. Notable movers include AON at USD 311.08 with a 2.77% increase, AVAT at USD 1.04 up 2.46%, and MRSH at USD 180.60 rising 2.09%.

More News

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
40 minutes ago
Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
40 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Bitcoin ETFs see $773M outflows in two days as BTC price hovers near $80,000 support level

Bitcoin ETFs see $773M outflows in two days as BTC price hovers near $80,000 support level

U.S. spot Bitcoin ETFs experienced significant outflows totaling $773.43 million over two days, with $137.94 million withdrawn on October 23 alone. Despite this, weekly ETF flows remain positive at around $228.2 million. The outflows coincided with F...

Market News
Neutral
4 hours ago
Apple briefly surpasses Nvidia as world's most valuable company on foldable iPhone launch day

Apple briefly surpasses Nvidia as world's most valuable company on foldable iPhone launch day

Apple's stock hit a record high on the launch day of its foldable iPhone Duo, briefly making it the world's most valuable company with a market cap of about $5.1 trillion, surpassing Nvidia. Despite strong demand and sold-out preorders, limited suppl...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App